IART

Healthcare Medical Devices

Integra LifeSciences Holdings Corporation

$12.68
-3.41 -21.19% today

Price History

Not enough data

Key Stats

Market Cap
986.16M
Avg Volume
878,021
EPS
-$0.09
52W High
$20.49
52W Low
$8.70
Div. Yield
0.0%

Analyst Ratings

Hold
1
Str Buy
2
Buy
6
Hold
0
Sell
2
Str Sell

Valuation

Forward P/E
4.88
P/B Ratio
0.95
P/S Ratio
0.60
EV/EBITDA
8.72
EV/Revenue
1.68
PEG Ratio
0.67

Margins

Gross Margin 56.9%
Operating Margin 9.6%
Net Margin (0.4%)
EBITDA Margin 19.2%

Growth & Returns

Revenue Growth (YoY)
0.8%
Return on Equity
(0.7%)
Return on Assets
2.8%

Liquidity & Leverage

Current Ratio
3.60
Quick Ratio
1.64
Debt / Equity
1.96
Total Cash
274.08M
Total Debt
2.05B

About

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

www.integralife.com